Compare NSAID

7 products »

close Created with Sketch.

Ilevro

Alcon, a Novartis Division

Ilevro (nepafenac ophthalmic suspension) 0.3% is a nonsteroidal, anti-inflammatory prodrug indicated for the treatment of pain and inflammation associated with cataract surgery.

At-a-Glance
  • Mechanism of Action: After topical ocular dosing, nepafenac penetrates the cornea and is converted by ocular tissue hydrolases to amfenac, a nonsteroidal anti-inflammatory drug. Nepafenac and amfenac are thought to inhibit the action of prostaglandin H synthase (cyclooxygenase), an enzyme required for prostaglandin production.
  • Dosage: One drop should be applied to the affected eye one-time-daily beginning 1 day prior to cataract surgery, continued on the day of surgery and through the first 2 weeks of the postoperative period. An additional drop should be administered 30 to 120 minutes prior to surgery.

Details

FDA

Yes

CE Mark

Not specified

Active Ingredients

Nepafenac

Application

Topical

Status

Prescription

Strength

0.3%

Company Information

Contact the company for additional information, availability, or pricing:

Alcon, a Novartis Division

alcon.com

6201 South Freeway

Fort Worth, TX 76134